E-LIB Suche - Ergebnisse für: Auguste, Peter

1

Translating potential improvement in the precision and accu..:

Patel, Mubarak ; Auguste, Peter ; Madan, Jason...
BJR|Artificial Intelligence. 1 (2024) 1 - p. , 2024

Link: https://doi.org/10.1093/..

2

The Growth Hormone Deficiency (GHD) Reversal Trial: effect ..:

Brettell, Elizabeth ; Högler, Wolfgang ; Woolley, Rebecca...
Trials. 24 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

3

Impact of updated trial data on the cost-effectiveness of p..:

Connock, Martin ; Auguste, Peter ; Obadia, Jean-François...
PLOS ONE. 18 (2023) 1 - p. e0280554 , 2023

Link: https://doi.org/10.1371/..

4

Potential impact on cost-effectiveness estimates of using i..:

Connock, Martin ; Auguste, Peter ; Capelle, Aude...
BMJ Open. 13 (2023) 3 - p. e060423 , 2023

Link: https://doi.org/10.1136/..

5

Is the assumption of waning of treatment effect applied con..:

Armoiry, Xavier ; Wang-Steverding, Xia ; Connock, Martin...
International Journal of Technology Assessment in Health Care. 38 (2022) 1 - p. , 2022

Link: https://doi.org/10.1017/..

6

OP135 Impact Of Updated Trial Data On The Cost-effectivenes..:

Armoiry, Xavier ; Auguste, Peter ; Obadia, Jean-François..
International Journal of Technology Assessment in Health Care. 37 (2021) S1 - p. 3-3 , 2021

Link: https://doi.org/10.1017/..

7

Cost-effectiveness of community health systems strengthenin..:

Kumar, Meghan Bruce ; Madan, Jason J ; Auguste, Peter...
BMJ Global Health. 6 (2021) 3 - p. e002452 , 2021

Link: https://doi.org/10.1136/..

8

A comparison of published time invariant Markov models with..:

Connock, Martin ; Auguste, Peter ; Armoiry, Xavier
The European Journal of Health Economics. 22 (2020) 1 - p. 89-100 , 2020

Link: https://doi.org/10.1007/..

9

Conflicting findings between the Mitra-Fr and the Coapt tri..:

Armoiry, Xavier ; Obadia, Jean-François ; Auguste, Peter..
PLOS ONE. 15 (2020) 11 - p. e0241361 , 2020

Link: https://doi.org/10.1371/..

10

Ocrelizumab for Treating Patients with Primary Progressive ..:

Auguste, Peter ; Colquitt, Jill ; Connock, Martin...
PharmacoEconomics. 38 (2020) 6 - p. 527-536 , 2020

Link: https://doi.org/10.1007/..

11

A Systematic Review of Economic Evaluations Assessing the C..:

Gallacher, Daniel ; Auguste, Peter ; Royle, Pamela..
Clinical Drug Investigation. 39 (2019) 12 - p. 1153-1174 , 2019

Link: https://doi.org/10.1007/..

12

How Do Pharmaceutical Companies Model Survival of Cancer Pa..:

Gallacher, Daniel ; Auguste, Peter ; Connock, Martin
International Journal of Technology Assessment in Health Care. 35 (2019) 2 - p. 160-167 , 2019

Link: https://doi.org/10.1017/..

13

Cost-effectiveness of tumor-treating fields added to mainte..:

Connock, Martin ; Auguste, Peter ; Dussart, Claude..
Journal of Neuro-Oncology. 143 (2019) 3 - p. 605-611 , 2019

Link: https://doi.org/10.1007/..

14

Pembrolizumab for Previously Treated Advanced or Metastatic..:

Gallacher, Daniel ; Armoiry, Xavier ; Auguste, Peter...
PharmacoEconomics. 37 (2018) 1 - p. 19-27 , 2018

Link: https://doi.org/10.1007/..

15

Comparative effectiveness of beta-interferons and glatirame..:

Melendez-Torres, G. J. ; Armoiry, Xavier ; Court, Rachel...
BMC Neurology. 18 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..